Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04180904 · ClinicalTrials.gov registry record · NA
Diet Interventions in Psoriatic Arthritis
A NA study of Psoriatic Arthritis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 2
- Study locations
NCT04180904: Completed NA study of Psoriatic Arthritis, sponsored by University of Pennsylvania.
NCT04180904 is a NA study of Psoriatic Arthritis that has completed, run by University of Pennsylvania. The registered enrollment target is 90 participants, below the 851-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04180904, a NA study of Psoriatic Arthritis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to learn whether changing diet impacts psoriatic arthritis (PsA).
Primary Outcome
Disease Activity in Psoriatic Arthritis (DAPSA) is a total of the 5 elements listed below to assess disease activity from both clinical and patient-reported data. The total score falls within a range to indicate level of disease activity: 0-4 = Remission (minimum); 5-14 = Low; 15-28 = Moderate; \>28 = High Disease Activity. There is no theoretical upper limit to the DAPSA score. Total DAPSA score = TJ (Tender Joints) + SJ (Swollen Joints) + CRP (C-reactive protein) + Activity + Pain 1. Tender
Conditions Studied
Interventions
- OTHER Diet 1
- OTHER Diet 2
Study Locations (2)
Pennsylvania
- University of Pennsylvania - Philadelphia
Ontario
- Women's College Hospital, University of Toronto - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2021-03-11 |
| Est. Completion | 2024-11-25 |
| Phase | NA |
What the finished NCT04180904 record still lists
NCT04180904 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 851-participant average among 48 other Psoriatic Arthritis trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Psoriatic Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Diet 1 is the first listed.
NCT04180904 reports a single indexed study location in Pennsylvania, Ontario.
Frequently Asked Questions
What is clinical trial NCT04180904 about?
NCT04180904 is a clinical study titled "Diet Interventions in Psoriatic Arthritis". The purpose of this study is to learn whether changing diet impacts psoriatic arthritis (PsA).
What is the current status of trial NCT04180904?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2021-03-11. Estimated completion is 2024-11-25.
What conditions does trial NCT04180904 study?
This clinical trial studies the following conditions: Psoriatic Arthritis.
What interventions are being tested in trial NCT04180904?
The interventions under investigation include: Diet 1 (OTHER), Diet 2 (OTHER).
Who is sponsoring clinical trial NCT04180904?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04180904 being conducted?
This trial has 2 study locations across Pennsylvania, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriatic Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04180904's enrollment target sits among peer trials
90 39th of 48 higher than 9 of 48 other Psoriatic Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psoriatic Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
RECRUITING · NA
-
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis
RECRUITING · NA
-
Psoriatic Arthritis D2P Screening
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
ACTIVE NOT RECRUITING · NA
-
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI